Copyright © 2011 Tian Li and Yaojiong Wu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. S. H. Orkin and L. I. Zon, “Hematopoiesis: an evolving paradigm for stem cell biology,” Cell, vol. 132, no. 4, pp. 631–644, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
2. Group SCTC, “Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials,” Journal of Clinical Oncology, vol. 23, no. 22, pp. 5074–5087, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. L. Murray, B. Chen, A. Galy et al., “Enrichment of human hematopoietic stem cell activity in the CD34⁺Thy- 1⁺Lin subpopulation from mobilized peripheral blood,” Blood, vol. 85, no. 2, pp. 368–378, 1995. View at Scopus
4. N. Flomenberg, S. M. Devine, J. F. DiPersio et al., “The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone,” Blood, vol. 106, no. 5, pp. 1867–1874, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
5. E. Gluckman, H. A. Broxmeyer, A. D. Auerbach et al., “Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling,” New England Journal of Medicine, vol. 321, no. 17, pp. 1174–1178, 1989. View at Scopus
6. L. Pierelli, G. Scambia, G. Bonanno et al., “CD34⁺/CD105⁺ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34⁺/CD38^low/- precursors,” British Journal of Haematology, vol. 108, no. 3, pp. 610–620, 2000. View at Publisher · View at Google Scholar · View at Scopus
7. S. J. Morrison and A. C. Spradling, “Stem cells and niches: mechanisms that promote stem cell maintenance throughout life,” Cell, vol. 132, no. 4, pp. 598–611, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
8. L. M. Calvi, G. B. Adams, K. W. Weibrecht et al., “Osteoblastic cells regulate the haematopoietic stem cell niche,” Nature, vol. 425, no. 6960, pp. 841–846, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
9. J. W. Zhang, C. Niu, L. Ye et al., “Identification of the haematopoietic stem cell niche and control of the niche size,” Nature, vol. 425, no. 6960, pp. 836–841, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
10. S. Méndez-Ferrer, D. Lucas, M. Battista, and P. S. Frenette, “Haematopoietic stem cell release is regulated by circadian oscillations,” Nature, vol. 452, no. 7186, pp. 442–447, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
11. T. Sugiyama, H. Kohara, M. Noda, and T. Nagasawa, “Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches,” Immunity, vol. 25, no. 6, pp. 977–988, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
12. M. Scheller, J. Huelsken, F. Rosenbauer et al., “Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation,” Nature Immunology, vol. 7, no. 10, pp. 1021–1023, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. T. Suda and F. Arai, “Wnt signaling in the niche,” Cell, vol. 132, no. 5, pp. 729–730, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. H. E. Fleming, V. Janzen, C. L. Celso et al., “Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo,” Cell Stem Cell, vol. 2, no. 3, pp. 274–283, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
15. P. Eliasson and J. Jönsson, “The hematopoietic stem cell niche: low in oxygen but a nice place to be,” Journal of Cellular Physiology, vol. 222, no. 1, pp. 17–22, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
16. K. Hosokawa, F. Arai, H. Yoshihara et al., “Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction,” Biochemical and Biophysical Research Communications, vol. 363, no. 3, pp. 578–583, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
17. M. F. Pittenger and B. J. Martin, “Mesenchymal stem cells and their potential as cardiac therapeutics,” Circulation Research, vol. 95, no. 1, pp. 9–20, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
18. M. Valtieri and A. Sorrentino, “The mesenchymal stromal cell contribution to homeostasis,” Journal of Cellular Physiology, vol. 217, no. 2, pp. 296–300, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
19. G. Kögler, S. Sensken, J. A. Airey et al., “A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential,” Journal of Experimental Medicine, vol. 200, no. 2, pp. 123–135, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
20. T. Tondreau, L. Lagneaux, M. Dejenefle et al., “Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation,” Differentiation, vol. 72, no. 7, pp. 319–326, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
21. J. E. Dennis and P. Charbord, “Origin and differentiation of human and murine stroma,” Stem Cells, vol. 20, no. 3, pp. 205–214, 2002. View at Scopus
22. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
23. E. Imai and T. Ito, “Can bone marrow differentiate into renal cells?” Pediatric Nephrology, vol. 17, no. 10, pp. 790–794, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. S. T. Mohanty, L. Kottam, A. Gambardella et al., “Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis,” Arthritis Research and Therapy, vol. 12, no. 4, p. R149, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. O. N. Koç, S. L. Gerson, B. W. Cooper et al., “Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy,” Journal of Clinical Oncology, vol. 18, no. 2, pp. 307–316, 2000. View at Scopus
26. K. L. Blanc, I. Rasmusson, B. Sundberg et al., “Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells,” Lancet, vol. 363, no. 9419, pp. 1439–1441, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
28. S. Mishima, A. Nagai, S. Abdullah et al., “Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent,” European Journal of Haematology, vol. 84, no. 6, pp. 538–546, 2010. View at Publisher · View at Google Scholar · View at PubMed
29. J. Zhang and L. Li, “Stem cell niche: microenvironment and beyond,” Journal of Biological Chemistry, vol. 283, no. 15, pp. 9499–9503, 2008. View at Publisher · View at Google Scholar · View at PubMed
30. M. L. Burness and D. A. Sipkins, “The stem cell niche in health and malignancy,” Seminars in Cancer Biology, vol. 20, no. 2, pp. 107–115, 2010. View at Publisher · View at Google Scholar · View at PubMed
31. B. S. Lam and G. B. Adams, “Hematopoietic stem cell lodgment in the adult bone marrow stem cell niche,” International Journal of Laboratory Hematology, vol. 32, no. 6, pp. 551–558, 2010. View at Publisher · View at Google Scholar · View at PubMed
32. J. M. Burns, B. C. Summers, Y. Wang et al., “A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development,” Journal of Experimental Medicine, vol. 203, no. 9, pp. 2201–2213, 2006. View at Publisher · View at Google Scholar · View at PubMed
33. P. T. Thevenot, A. M. Nair, J. Shen, P. Lotfi, C. Y. Ko, and L. Tang, “The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory response,” Biomaterials, vol. 31, no. 14, pp. 3997–4008, 2010. View at Publisher · View at Google Scholar · View at PubMed
34. I. Rappold, S. M. Watt, N. Kusadasi, S. Rose-John, J. Hatzfeld, and R. E. Ploemacher, “Gp130-signaling synergizes with FL and TPO for the long-term expansion of cord blood progenitors,” Leukemia, vol. 13, no. 12, pp. 2036–2048, 1999.
35. J. Y. Han, R. Y. Goh, S. Y. Seo, et al., “Cotransplantation of cord blood hematopoietic stem cells and culture-expanded and GM-CSF-/SCF-transfected mesenchymal stem cells in SCID mice,” Journal of Korean Medical Science, vol. 22, no. 2, pp. 242–247, 2007.
36. A. Bernstein, L. Forrester, A. D. Reith, P. Dubreuil, and R. Rottapel, “The murine W/c-kit and steel loci and the control of hematopoiesis,” Seminars in Hematology, vol. 28, no. 2, pp. 138–142, 1991.
37. M. Verfaillie, “Adhesion receptors as regulators of the hematopoietic process,” Blood, vol. 92, no. 8, pp. 2609–2612, 1998.
38. R. Schofield, “The relationship between the spleen colony-forming cell and the haemopoietic stem cell,” Blood Cells, vol. 4, no. 1-2, pp. 7–25, 1978.
39. R. W. Garrett and S. G. Emerson, “Bone and blood vessels: the hard and the soft of hematopoietic stem cell niches,” Cell Stem Cell, vol. 105, no. 4, pp. 503–506, 2009. View at Publisher · View at Google Scholar · View at PubMed
40. E. Fuchs, T. Tumbar, and G. Guasch, “Socializing with the neighbors: stem cells and their niche,” Cell, vol. 116, no. 6, pp. 769–778, 2004. View at Publisher · View at Google Scholar
41. F. Fierro, T. Illmer, D. Jing et al., “Inhibition of platelet-derived growth factor receptor-β by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro,” Cell Proliferation, vol. 40, no. 3, pp. 355–366, 2007. View at Publisher · View at Google Scholar · View at PubMed
42. B. Sacchetti, A. Funari, S. Michienzi et al., “Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment,” Cell, vol. 131, no. 2, pp. 324–336, 2007. View at Publisher · View at Google Scholar · View at PubMed
43. M. J. Kiel, O. H. Yilmaz, T. Iwashita, O. H. Yilmaz, C. Terhorst, and S. J. Morrison, “SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells,” Cell, vol. 121, no. 7, pp. 1109–1121, 2005. View at Publisher · View at Google Scholar · View at PubMed
44. T. Yin and L. Li, “The stem cell niches in bone,” Journal of Clinical Investigation, vol. 116, no. 5, pp. 1195–1201, 2006. View at Publisher · View at Google Scholar · View at PubMed
45. M. H. Raaijmakers, “Regulating traffic in the hematopoietic stem cell niche,” Haematologica, vol. 95, no. 9, pp. 1439–1441, 2010. View at Publisher · View at Google Scholar · View at PubMed
46. B. Heissig, K. Hattori, S. Dias et al., “Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand,” Cell, vol. 109, no. 5, pp. 625–637, 2002. View at Publisher · View at Google Scholar
47. F. Arai, A. Hirao, M. Ohmura et al., “Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche,” Cell, vol. 118, no. 2, pp. 149–161, 2004. View at Publisher · View at Google Scholar · View at PubMed
48. Y. Xie, T. Yin, W. Wiegraebe, et al., “Detection of functional haematopoietic stem cell niche using real-time imaging,” Nature, vol. 457, no. 7225, pp. 97–101, 2009. View at Publisher · View at Google Scholar · View at PubMed
49. R. S. Taichman and S. G. Emerson, “The role of osteoblasts in the hematopoietic microenvironment,” Stem Cells, vol. 16, no. 1, pp. 7–15, 1998.
50. Y. Muguruma, T. Yahata, H. Miyatake et al., “Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment,” Blood, vol. 107, no. 5, pp. 1878–1887, 2006. View at Publisher · View at Google Scholar · View at PubMed
51. S. Méndez-Ferrer, T. V. Michurina, F. Ferraro et al., “Mesenchymal and haematopoietic stem cells form a unique bone marrow niche,” Nature, vol. 466, no. 12, pp. 829–834, 2010. View at Publisher · View at Google Scholar · View at PubMed
52. M. K. Majumdar, M. A. Thiede, S. E. Haynesworth, S. P. Bruder, and S. L. Gerson, “Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages,” Journal of Hematotherapy and Stem Cell Research, vol. 9, no. 6, pp. 841–848, 2000. View at Publisher · View at Google Scholar · View at PubMed
53. L. Shi and L. H. Hu, “The normal flora may contribute to the quantitative preponderance of myeloid cells under physiological conditions,” Medical Hypotheses, vol. 21, no. 12, pp. 141–143, 2011. View at Publisher · View at Google Scholar · View at PubMed
54. K. S. Jeltsch, T. F. Radke, S. Laufs et al., “Unrestricted somatic stem cells: interaction with CD34⁺ cells in vitro and in vivo, expression of homing genes and exclusion of tumorigenic potential,” Cytotherapy, vol. 13, no. 3, pp. 357–365, 2011. View at Publisher · View at Google Scholar · View at PubMed
55. B. B. Ratliff, N. Singh, K. Yasuda et al., “Mesenchymal stem cells, used as bait, disclose tissue binding sites,” American Journal of Pathology, vol. 177, no. 2, pp. 873–883, 2010. View at Publisher · View at Google Scholar · View at PubMed
56. J. Y. Ahn, G. Park, J. S. Shim, J. W. Lee, and I. H. Oh, “Intramarrow injection of β-catenin-activated, but not naïve mesenchymal stromal cells stimulates self-renewal of hematopoietic stem cells in bone marrow,” Experimental and Molecular Medicine, vol. 42, no. 2, pp. 122–131, 2010. View at Publisher · View at Google Scholar · View at PubMed
57. M. Tavassoli and A. Friedenstein, “Hemopoietic stromal microenvironment,” American Journal of Hematology, vol. 15, no. 2, pp. 195–203, 1983.
58. P. A. Marks, V. M. Richon, and R. A. Rifkind, “Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells,” Journal of the National Cancer Institute, vol. 92, no. 15, pp. 1210–1216, 2000.
59. A. P. Wolffe, P. L. Jones, and P. A. Wade, “DNA demethylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 11, pp. 5894–5896, 1999. View at Publisher · View at Google Scholar
60. S. H. Koh, H. S. Choi, E. S. Park, H. J. Kang, H. S. Ahn, and H. Y. Shin, “Co-culture of human CD34⁺ cells with mesenchymal stem cells increases the survival of CD34⁺ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death,” Biochemical and Biophysical Research Communications, vol. 329, no. 3, pp. 1039–1045, 2005. View at Publisher · View at Google Scholar · View at PubMed
61. M. Tabata, A. Satake, N. Okura, et al., “Long-term outcome after allogeneic bone marrow transplantation for hematological malignancies with non-remission status. Results of a single-center study of 24 patients,” Annals of Hematology, vol. 81, no. 10, pp. 582–587, 2002.
62. L. M. Ball, M. E. Bernardo, H. Roelofs et al., “Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation,” Blood, vol. 110, no. 7, pp. 2764–2767, 2007. View at Publisher · View at Google Scholar · View at PubMed
63. S. Hombach-Klonisch, S. Panigrahi, I. Rashedi et al., “Adult stem cells and their trans-differentiation potential-perspectives and therapeutic applications,” Journal of Molecular Medicine, vol. 86, no. 12, pp. 1301–1314, 2008. View at Publisher · View at Google Scholar · View at PubMed
64. R. Iannone, J. F. Casella, E. J. Fuchs et al., “Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia,” Biology of Blood and Marrow Transplantation, vol. 9, no. 8, pp. 519–528, 2003. View at Publisher · View at Google Scholar
65. S. Y. Pai, D. DeMartiis, C. Forino et al., “Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation,” Biology of Blood and Marrow Transplantation, vol. 38, no. 10, pp. 671–679, 2006. View at Publisher · View at Google Scholar · View at PubMed
66. C. Peters and W. Krivit, “Hematopoietic cell transplantation for mucopolysaccharidosis IIB (Hunter syndrome),” Bone Marrow Transplantation, vol. 25, no. 10, pp. 1097–1099, 2000.
67. M. Salerno, R. Busiello, V. Esposito et al., “Allogeneic bone marrow transplantation restores IGF-I production and linear growth in a γ-SCID patient with abnormal growth hormone receptor signaling,” Bone Marrow Transplantation, vol. 33, no. 7, pp. 773–775, 2004. View at Publisher · View at Google Scholar · View at PubMed
68. S. L. Staba, M. L. Escolar, M. Poe et al., “Cord-blood transplants from unrelated donors in patients with hurler's syndrome,” New England Journal of Medicine, vol. 350, no. 19, pp. 1960–1969, 2004. View at Publisher · View at Google Scholar · View at PubMed
69. T. Kurokawa, K. Fischer, H. Bertz, S. Hoegerle, J. Finke, and A. Mackensen, “In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation,” International Journal of Cancer, vol. 101, no. 1, pp. 52–60, 2002. View at Publisher · View at Google Scholar · View at PubMed
70. B. Maitra, E. Szekely, K. Gjini et al., “Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation,” Bone Marrow Transplantation, vol. 33, no. 6, pp. 597–604, 2004. View at Publisher · View at Google Scholar · View at PubMed
71. I. Resnick, P. Stepensky, G. Elkin et al., “MSC for the improvement of hematopoietic engraftment,” Bone Marrow Transplantation, vol. 45, no. 3, pp. 605–606, 2010. View at Publisher · View at Google Scholar · View at PubMed
72. R. M. El Backly and R. Cancedda, “Bone marrow stem cells in clinical application: harnessing paracrine roles and niche mechanisms,” Advances in Biochemical Engineering/Biotechnology, vol. 123, pp. 265–292, 2010.
73. I. McNiece, J. Harrington, J. Turney, J. Kellner, and E. J. Shpall, “Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells,” Cytotherapy, vol. 6, no. 4, pp. 311–317, 2004. View at Publisher · View at Google Scholar · View at PubMed
74. N. Nakao, T. Nakayama, T. Yahata et al., “Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo,” American Journal of Pathology, vol. 177, no. 2, pp. 547–554, 2010. View at Publisher · View at Google Scholar · View at PubMed
75. A. V. Vanikar, H. L. Trivedi, A. Feroze, K. V. Kanodia, S. D. Dave, and P. R. Shah, “Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness,” International Urology and Nephrology, vol. 43, no. 1, pp. 225–232, 2010. View at Publisher · View at Google Scholar · View at PubMed
76. W. A. Noort, A. B. Kruisselbrink, P. S. In't Anker et al., “Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34⁺ cells in NOD/SCID mice,” Experimental Hematology, vol. 30, no. 8, pp. 870–878, 2002. View at Publisher · View at Google Scholar · View at Scopus
77. I. R. Lemischka, “Microenvironmental regulation of hematopoietic stem cells,” Stem Cells, vol. 15, no. 1, pp. 63–68, 1997.
78. M. Angelopoulou, E. Novelli, J. E. Grove et al., “Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice,” Experimental Hematology, vol. 31, no. 5, pp. 413–420, 2003. View at Publisher · View at Google Scholar
79. D. H. Kim, K. H. Yoo, Y. S. Yim, et al., “Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice,” Journal of Korean Medical Science, vol. 21, no. 6, pp. 1000–1004, 2006.
80. C. L. da Silva, R. Gonçalves, K. B. Crapnell, J. M. Cabral, E. D. Zanjani, and G. Almeida-Porada, “A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells,” Experimental Hematology, vol. 33, no. 7, pp. 828–835, 2005. View at Publisher · View at Google Scholar · View at PubMed
81. R. Gonçalves, C. L. da Silva, J. M. S. Cabral, E. D. Zanjani, and G. Almeida-Porada, “A Stro-1⁺ human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system,” Experimental Hematology, vol. 34, no. 10, pp. 1353–1359, 2006. View at Publisher · View at Google Scholar · View at PubMed
82. N. G. Chung, D. C. Jeong, S. J. Park et al., “Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation,” International Journal of Hematology, vol. 80, no. 4, pp. 370–376, 2004. View at Publisher · View at Google Scholar
83. O. Gurevitch, T. B. Prigozhina, T. Pugatsch, and S. Slavin, “Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment,” Transplantation, vol. 68, no. 9, pp. 1362–1368, 1999.
84. A. Stanevsky, A. Shimoni, R. Yerushalmi, and A. Nagler, “Cord blood stem cells for hematopoietic transplantation,” Stem Cell Reviews and Reports, vol. 7, pp. 425–433, 2011. View at Publisher · View at Google Scholar · View at PubMed
85. M. Battiwalla and P. Hematti, “Mesenchymal stem cells in hematopoietic stem cell transplantation,” Cytotherapy, vol. 11, no. 5, pp. 503–515, 2009. View at Publisher · View at Google Scholar · View at PubMed
86. K. Sugiura, H. Hisha, J. Ishikawa et al., “Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro,” Stem Cells, vol. 19, no. 1, pp. 46–58, 2001.
87. R. Abdi, P. Fiorina, C. N. Adra, M. Atkinson, and M. H. Sayegh, “Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes,” Diabetes, vol. 57, no. 7, pp. 1759–1767, 2008. View at Publisher · View at Google Scholar · View at PubMed
88. R. E. Newman, D. Yoo, M. A. LeRoux, and A. Danilkovitch-Miagkova, “Treatment of inflammatory diseases with mesenchymal stem cells,” Inflammation and Allergy-Drug Targets, vol. 8, no. 2, pp. 110–123, 2009. View at Publisher · View at Google Scholar
89. M. Krampera, S. Glennie, J. Dyson et al., “Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide,” Blood, vol. 101, no. 9, pp. 3722–3729, 2003. View at Publisher · View at Google Scholar · View at PubMed
90. F. Dazzi and F. M. Marelli-Berg, “Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells,” European Journal of Immunology, vol. 38, no. 6, pp. 1479–1482, 2008. View at Publisher · View at Google Scholar · View at PubMed
91. K. Le Blanc, I. Rasmusson, C. Gőtherstrőm et al., “Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes,” Scandinavian Journal of Immunology, vol. 60, no. 3, pp. 307–315, 2004. View at Publisher · View at Google Scholar · View at PubMed
92. A. Corcione, F. Benvenuto, E. Ferretti et al., “Human mesenchymal stem cells modulate B-cell functions,” Blood, vol. 107, no. 1, pp. 367–372, 2006. View at Publisher · View at Google Scholar · View at PubMed
93. K. English, F. P. Barry, and B. P. Mahon, “Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation,” Immunology Letters, vol. 115, no. 1, pp. 50–58, 2008. View at Publisher · View at Google Scholar · View at PubMed
94. H. Y. Lai, M. J. Yang, K. C. Wen, K. C. Chao, C. C. Shih, and O. K. Lee, “Mesenchymal stem cells negatively regulate dendritic lineage commitment of umbilical-cord-blood-derived hematopoietic stem cells: an unappreciated mechanism as immunomodulators,” Tissue Engineering, vol. 16, no. 9, pp. 2987–2997, 2010. View at Publisher · View at Google Scholar · View at PubMed
95. S. Pulavendran, J. Vignesh, and C. Rose, “Differential anti-inflammatory and anti-fibrotic activity of transplanted mesenchymal vs. hematopoietic stem cells in carbon tetrachloride-induced liver injury in mice,” International Immunopharmacology, vol. 10, no. 4, pp. 513–519, 2010. View at Publisher · View at Google Scholar · View at PubMed
96. D. Polchert, J. Sobinsky, G. Douglas et al., “IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease,” European Journal of Immunology, vol. 38, no. 6, pp. 1745–1755, 2008. View at Publisher · View at Google Scholar · View at PubMed
97. G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta, “Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation,” Blood, vol. 107, no. 4, pp. 1484–1490, 2006. View at Publisher · View at Google Scholar · View at PubMed
98. S. Ghannam, C. Bouffi, F. Djouad, C. Jorgensen, and D. Noël, “Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications,” Stem Cell Research and Therapy, vol. 1, no. 1, pp. 2–8, 2010. View at Publisher · View at Google Scholar · View at PubMed
99. A. Chapel, J. M. Bertho, M. Bensidhoum et al., “Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome,” Journal of Gene Medicine, vol. 5, no. 12, pp. 1028–1038, 2003. View at Publisher · View at Google Scholar · View at PubMed